{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:37:49Z","timestamp":1790336269768,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/md.0b013e3181e9442f","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T04:21:32Z","timestamp":1278562892000},"page":"245-250","source":"Crossref","is-referenced-by-count":73,"title":["Cardiomyopathy in Congenital and Acquired Generalized Lipodystrophy"],"prefix":"10.1097","volume":"89","author":[{"given":"Beatrice C.","family":"Lupsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea O.","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Gorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"R2-7-20210309","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-7-20210309","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-0004.2002.610407.x","article-title":"Cardiomyopathy in congenital complete lipodystrophy.","volume":"61","author":"Bhayana","year":"2002","journal-title":"Clin Genet"},{"key":"R4-7-20210309","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00441777","article-title":"Echocardiographic assessment of cardiac function and morphology in patients with generalised lipodystrophy.","volume":"144","author":"Bjornstad","year":"1985","journal-title":"Eur J Pediatr"},{"key":"R5-7-20210309","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.","volume":"88","author":"Caux","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-7-20210309","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy.","volume":"53","author":"Chong","year":"2009","journal-title":"Diabetologia"},{"key":"R7-7-20210309","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"R8-7-20210309","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"R9-7-20210309","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2169\/internalmedicine1962.28.534","article-title":"Total lipodystrophy with heart failure and renal failure: report of a case.","volume":"28","author":"Ishii","year":"1989","journal-title":"Jpn J Med"},{"key":"R10-7-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2005.10.018","article-title":"Laminopathies: multisystem dystrophy syndromes.","volume":"87","author":"Jacob","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R11-7-20210309","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.","volume":"54","author":"Javor","year":"2005","journal-title":"Diabetes"},{"key":"R12-7-20210309","first-page":"196","article-title":"Dilated cardiomyopathy and myocardial infarction secondary to congenital generalized lipodystrophy.","volume":"J35","author":"Khalife","year":"2008","journal-title":"Tex Heart Inst"},{"key":"R13-7-20210309","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-7-20210309","first-page":"50","article-title":"Cardiomyopathy in lipodystrophy and the specificity spillover hypothesis.","volume":"29","author":"Klar","year":"1993","journal-title":"Isr J Med Sci"},{"key":"R15-7-20210309","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"R16-7-20210309","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(46)90528-4","article-title":"Lipodystrophy and hepatomegaly with diabetes, lipidaemia, and other metabolic disturbances.","volume":"247","author":"Lawrence","year":"1946","journal-title":"Lancet"},{"key":"R17-7-20210309","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1073\/pnas.0405499101","article-title":"Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.","volume":"101","author":"Lee","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-7-20210309","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"R20-7-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.10437","article-title":"Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman.","volume":"110","author":"Rajab","year":"2002","journal-title":"Am J Med Genet"},{"key":"R21-7-20210309","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3476(86)80389-4","article-title":"Hypertrophic cardiomyopathy in total lipodystrophy.","volume":"109","author":"Rheuban","year":"1986","journal-title":"J Pediatr"},{"key":"R22-7-20210309","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"R23-7-20210309","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatr"},{"key":"R24-7-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","article-title":"Generalized lipodystrophy, congenital and acquired (lipoatrophy).","volume":"413","author":"Seip","year":"1996","journal-title":"Acta Paediatr Suppl"},{"key":"R25-7-20210309","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.107.160457","article-title":"Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America.","volume":"101","author":"Szczepaniak","year":"2007","journal-title":"Circ Res"},{"key":"R26-7-20210309","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"R27-7-20210309","first-page":"243","article-title":"Cardiac involvement in total generalized lipodystrophy (Berardinelli-Seip syndrome).","volume":"75","author":"Viegas","year":"2002","journal-title":"Arq Bras Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181e9442f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:32Z","timestamp":1786040912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201007000-00007"}},"subtitle":["A Clinical Assessment"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181e9442f","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}